Families of Ross Otto Hambrick and Victor Marcellus King have filed a federal suit alleging the United States government enrolled the Black infants in a mid‑1960s respiratory syncytial virus trial without parental consent in a federally funded study. The boys received the experimental RSV vaccine at a Washington, D.C., children’s clinic in 1965‑66 and died a year later from the disease and bacterial pneumonia.

Civil‑rights attorney Ben Crump told reporters the study prioritized market speed over the children’s safety, a public view reflected in a 2023 Undark Magazine investigation that first uncovered the boys’ names in a government lab notebook, the lawsuit alleges, and raises ethical questions today still. The families claim wrongful death, lack of informed consent and civil battery, seeking unspecified damages; tissue samples taken at autopsy were pivotal in developing the vaccine now used worldwide.

The case arrives as the first RSV vaccine received FDA approval in 2023, unlocking a multibillion‑dollar market for manufacturers and prompting renewed scrutiny of historic research practices. If the government faces liability, it could reshape how federal agencies contract with biotech firms and force stricter consent protocols, potentially raising costs for future vaccine development and could prompt congressional hearings on research oversight for future trials.